The Cell-rounding Activity of the Vesicular Stomatitis Virus Matrix Protein is Due to the Induction of Cell Death

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 2003 Apr 15

PMID 12692256

Citations 28

Authors

Sarah A Kopecky

Douglas S Lyles

Affiliations

Soon will be listed here.

Abstract

The matrix (M) protein of vesicular stomatitis virus (VSV) expressed in the absence of other viral components causes many of the cytopathic effects of VSV, including an inhibition of host gene expression and the induction of cell rounding. It was recently shown that M protein also induces apoptosis in the absence of other viral components. This raises the possibility that the activation of apoptotic pathways causes the inhibition of host gene expression and cell rounding by M protein. To test this hypothesis, host gene expression and cell rounding were analyzed after the transfection of M mRNA into HeLa cells stably overexpressing Bcl-2 (HeLa-Bcl-2 cells). We have shown previously that Bcl-2 inhibits M-protein-induced apoptosis. Here, we show that activation of the apoptotic pathways downstream of Bcl-2 is not required for the inhibition of host gene expression by M protein. In contrast, overexpression of Bcl-2 inhibited cell rounding induced by M protein, indicating that apoptotic pathways downstream of Bcl-2 are required for the cell-rounding activities of M protein.

Citing Articles

Patient-derived head and neck tumor slice cultures: a versatile tool to study oncolytic virus action.

Runge A, Mayr M, Schwaiger T, Sprung S, Chetta P, Gottfried T Sci Rep. 2022; 12(1):15334.

PMID: 36097280 PMC: 9467994. DOI: 10.1038/s41598-022-19555-0.

The VSV matrix protein inhibits NF-κB and the interferon response independently in mouse L929 cells.

Marquis K, Becker R, Weiss A, Morris M, Ferran M Virology. 2020; 548:117-123.

PMID: 32838932 PMC: 7447837. DOI: 10.1016/j.virol.2020.06.013.

Lentivector Producer Cell Lines with Stably Expressed Vesiculovirus Envelopes.

Tijani M, Munis A, Perry C, Sanber K, Ferraresso M, Mukhopadhyay T Mol Ther Methods Clin Dev. 2018; 10:303-312.

PMID: 30182034 PMC: 6118154. DOI: 10.1016/j.omtm.2018.07.013.

The glycoprotein of vesicular stomatitis virus promotes release of virus-like particles from tetherin-positive cells.

Brinkmann C, Hoffmann M, Lubke A, Nehlmeier I, Kramer-Kuhl A, Winkler M PLoS One. 2017; 12(12):e0189073.

PMID: 29216247 PMC: 5720808. DOI: 10.1371/journal.pone.0189073.

The vesicular stomatitis virus matrix protein inhibits NF-κB activation in mouse L929 cells.

Varble A, Ried C, Hammond W, Marquis K, Woodruff M, Ferran M Virology. 2016; 499:99-104.

PMID: 27643886 PMC: 5102766. DOI: 10.1016/j.virol.2016.09.009.

References

Vikman K, Robertson B, Grant G, Liljeborg A, Kristensson K . Interferon-gamma receptors are expressed at synapses in the rat superficial dorsal horn and lateral spinal nucleus. J Neurocytol. 2000; 27(10):749-59. DOI: 10.1023/a:1006903002044. View

Neely M, Sidell K, Graham D, Montine T . The lipid peroxidation product 4-hydroxynonenal inhibits neurite outgrowth, disrupts neuronal microtubules, and modifies cellular tubulin. J Neurochem. 1999; 72(6):2323-33. DOI: 10.1046/j.1471-4159.1999.0722323.x. View

Petersen J, Her L, Varvel V, Lund E, Dahlberg J . The matrix protein of vesicular stomatitis virus inhibits nucleocytoplasmic transport when it is in the nucleus and associated with nuclear pore complexes. Mol Cell Biol. 2000; 20(22):8590-601. PMC: 102164. DOI: 10.1128/MCB.20.22.8590-8601.2000. View

Yuan H, Puckett S, Lyles D . Inhibition of host transcription by vesicular stomatitis virus involves a novel mechanism that is independent of phosphorylation of TATA-binding protein (TBP) or association of TBP with TBP-associated factor subunits. J Virol. 2001; 75(9):4453-8. PMC: 114196. DOI: 10.1128/JVI.75.9.4453-4458.2001. View

Kopecky S, Willingham M, Lyles D . Matrix protein and another viral component contribute to induction of apoptosis in cells infected with vesicular stomatitis virus. J Virol. 2001; 75(24):12169-81. PMC: 116113. DOI: 10.1128/JVI.75.24.12169-12181.2001. View

von Kobbe C , van Deursen JM , Rodrigues J, Sitterlin D, Bachi A, Wu X . Vesicular stomatitis virus matrix protein inhibits host cell gene expression by targeting the nucleoporin Nup98. Mol Cell. 2000; 6(5):1243-52. DOI: 10.1016/s1097-2765(00)00120-9. View

Connor J, Lyles D . Vesicular stomatitis virus infection alters the eIF4F translation initiation complex and causes dephosphorylation of the eIF4E binding protein 4E-BP1. J Virol. 2002; 76(20):10177-87. PMC: 136556. DOI: 10.1128/jvi.76.20.10177-10187.2002. View

Ahmed M, McKenzie M, Puckett S, Hojnacki M, Poliquin L, Lyles D . Ability of the matrix protein of vesicular stomatitis virus to suppress beta interferon gene expression is genetically correlated with the inhibition of host RNA and protein synthesis. J Virol. 2003; 77(8):4646-57. PMC: 152115. DOI: 10.1128/jvi.77.8.4646-4657.2003. View

Kopecky S, Lyles D . Contrasting effects of matrix protein on apoptosis in HeLa and BHK cells infected with vesicular stomatitis virus are due to inhibition of host gene expression. J Virol. 2003; 77(8):4658-69. PMC: 152120. DOI: 10.1128/jvi.77.8.4658-4669.2003. View

10.

Wang E, Goldman R . Functions of cytoplasmic fibers in intracellular movements in BHK-21 cells. J Cell Biol. 1978; 79(3):708-26. PMC: 2110264. DOI: 10.1083/jcb.79.3.708. View

11.

Newcomb W, Brown J . Role of the vesicular stomatitis virus matrix protein in maintaining the viral nucleocapsid in the condensed form found in native virions. J Virol. 1981; 39(1):295-9. PMC: 171289. DOI: 10.1128/JVI.39.1.295-299.1981. View

12.

Blondel D, Harmison G, Schubert M . Role of matrix protein in cytopathogenesis of vesicular stomatitis virus. J Virol. 1990; 64(4):1716-25. PMC: 249309. DOI: 10.1128/JVI.64.4.1716-1725.1990. View

13.

Kaptur P, Rhodes R, Lyles D . Sequences of the vesicular stomatitis virus matrix protein involved in binding to nucleocapsids. J Virol. 1991; 65(3):1057-65. PMC: 239871. DOI: 10.1128/JVI.65.3.1057-1065.1991. View

14.

Black B, Lyles D . Vesicular stomatitis virus matrix protein inhibits host cell-directed transcription of target genes in vivo. J Virol. 1992; 66(7):4058-64. PMC: 241208. DOI: 10.1128/JVI.66.7.4058-4064.1992. View

15.

Black B, Rhodes R, McKenzie M, Lyles D . The role of vesicular stomatitis virus matrix protein in inhibition of host-directed gene expression is genetically separable from its function in virus assembly. J Virol. 1993; 67(8):4814-21. PMC: 237868. DOI: 10.1128/JVI.67.8.4814-4821.1993. View

16.

Huneycutt B, Bi Z, Aoki C, Reiss C . Central neuropathogenesis of vesicular stomatitis virus infection of immunodeficient mice. J Virol. 1993; 67(11):6698-706. PMC: 238109. DOI: 10.1128/JVI.67.11.6698-6706.1993. View

17.

Barge A, Gaudin Y, Coulon P, Ruigrok R . Vesicular stomatitis virus M protein may be inside the ribonucleocapsid coil. J Virol. 1993; 67(12):7246-53. PMC: 238187. DOI: 10.1128/JVI.67.12.7246-7253.1993. View

18.

Black B, Brewer G, Lyles D . Effect of vesicular stomatitis virus matrix protein on host-directed translation in vivo. J Virol. 1994; 68(1):555-60. PMC: 236321. DOI: 10.1128/JVI.68.1.555-560.1994. View

19.

Muller U, Steinhoff U, Reis L, Hemmi S, Pavlovic J, Zinkernagel R . Functional role of type I and type II interferons in antiviral defense. Science. 1994; 264(5167):1918-21. DOI: 10.1126/science.8009221. View

20.

Melki R, Gaudin Y, Blondel D . Interaction between tubulin and the viral matrix protein of vesicular stomatitis virus: possible implications in the viral cytopathic effect. Virology. 1994; 202(1):339-47. DOI: 10.1006/viro.1994.1350. View